Long-term effectiveness of thymectomy in late-onset myasthenia gravis
Our findings suggest that thymectomy may be a feasible and potentially beneficial therapeutic option in this MG subgroup, possibly increasing the likelihood of disease remission without ongoing immunosuppressive therapy.
Authors
- Marco Lucchi (ORCID: https://orcid.org/0000-0001-9909-6820)
- Ester Latini (ORCID: https://orcid.org/0009-0000-7474-3681)
- Gabriele Siciliano (ORCID: https://orcid.org/0000-0002-6142-2384)
- Gaetano Romano (ORCID: https://orcid.org/0000-0003-3654-4651)
- Carmelina Cristina Zirafa (ORCID: https://orcid.org/0000-0003-3240-9313)
- Melania Guida (ORCID: https://orcid.org/0000-0003-1968-5874)
- Vittorio Aprile (ORCID: https://orcid.org/0000-0001-8538-1719)
- Michelangelo Maestri Tassoni
- Roberta Ricciardi (ORCID: https://orcid.org/0009-0006-9506-0904)
- Alba Cepele
Institutions
- University of Pisa (IT)
- University of Salerno (IT)
- University of Florence (IT)
Publication Details
- Journal
- Journal of Neurology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1007/s00415-025-13424-2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Firenze